In a treatment, how important is it to have the right diagnosis?
What if the cancer that you are diagnosed with, has a risk associated with your family tree?
With so much research going on in this space, how essential is it to know the detection and classification of the mutation variants?
These are some of the most common questions that may pop-up in each of ours’ minds. Needless to state, we all are familiar with, how important it is to accurately DIAGNOSE so as to effectively TREAT and PLAN for the management of cancer. But we often miss to wisely choose the diagnostic options from the wide arena of available options.
For cancers, related to mutations in BRCA1 and BRCA2 gene and syndromes such as Hereditary Breast/Ovarian Cancer (HBOC), we now have molecular diagnostic test BRACAnalysis. This test performs the genetic testing using full sequencing (Sanger sequencing) and detection for large rearrangements. In the latter case, 10% of the mutations in high risk patients undergo rearrangements in the BRCA1 and BRCA2 genes. Myriad uses a robust technology named the Multiplex Ligation Dependent Probe Amplification (MLPA) system to detect these rearrangements.
The BRACAnalysis helps to map the journey in the most effective and accurate manner. It helps to assess the HBOC risk by screening (screen the patient/ family history), evaluating (discuss BRACAnalysis with patients), diagnosing (perform test and interpret the result) and managing (design a robust management plan) the syndrome.
In addition to this, a couple of reasons outwardly convinces me more to pick the Myriad’s BRACAnalysis Testing kit than any other. Some of them are:
-Both, on paper and practice, Myriad claims to be the most accurate and the fastest to provide the results. It banks on the published data that states the accuracy achieved using the BRACAnalysis Kit.
-With over 20 years of expertise and experience in this field, Myriad can be called to have spearheaded this market and managed to serve as a forerunner too.
-The unique technology used by Myriad has explicitly classified over 60% mutations using the several unique methods optimized by Myriad
-In terms of numbers, over 2 million patients have been tested for hereditary cancer using Myriad’s BRACAnalysis testing kit.
High analytical and interpretative accuracy will fetch a patient and the doctor the most reliable diagnostic results. Therefore, while picking, make sure you do not compromise onto the quality, reliability, accuracy and of course comprehensiveness offered.